| Income Statement |
| Total Revenue | 14.66M |
|
| Revenues (USD) | 14.66M |
| Cost of Revenue | 6.64M |
| Gross Profit | 8.02M |
| Operating Expenses | 166.14M |
| Research and Development Expense | 122.37M |
| Selling, General and Administrative Expense | 43.77M |
| Operating Income | -158.12M |
| Interest Expense | 3.66M |
| Income Tax Expense | 267.00K |
| Net Income | -148.75M |
| Net Income Common Stock | -148.75M |
| Net Income Common Stock (USD) | -148.75M |
| Consolidated Income | -148.75M |
| Earnings per Basic Share | -0.64 |
| Earnings per Basic Share (USD) | -0.64 |
| Earnings per Diluted Share | -0.64 |
| Earning Before Interest & Taxes (EBIT) | -144.82M |
| Earning Before Interest & Taxes (USD) | -144.82M |
| Weighted Average Shares | 230.76M |
| Balance Sheet |
| Cash and Equivalents | 1.48B |
| Cash and Equivalents (USD) | 1.48B |
| Trade and Non-Trade Receivables | 3.61M |
| Current Assets | 1.50B |
| Property, Plant & Equipment Net | 423.43M |
| Total Assets | 1.93B |
| Debt Current | 10.41M |
| Total Debt | 206.70M |
| Current Liabilities | 103.91M |
| Debt Non-Current | 196.29M |
| Total Liabilities | 318.27M |
| Accumulated Retained Earnings (Deficit) | -2.18B |
| Accumulated Other Comprehensive Income | -199.00K |
| Shareholders Equity | 1.62B |
| Shareholders Equity (USD) | 1.62B |
| Assets Non-Current | 429.83M |
| Total Debt (USD) | 206.70M |
| Deferred Revenue | 21.89M |
| Liabilities Non-Current | 214.37M |
| Trade and Non-Trade Payables | 22.81M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 6.32M |
| Net Cash Flow from Financing | 6.13M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -109.93M |
| Capital Expenditure | -41.11M |
| Issuance (Purchase) of Equity Shares | 7.62M |
| Issuance (Repayment) of Debt Securities | -1.44M |
| Net Cash Flow from Investing | -41.11M |
| Net Cash Flow from Operations | -74.88M |
| Effect of Exchange Rate Changes on Cash | -65.00K |
| Share Based Compensation | 14.67M |